TY  - JOUR
T1  - Gemcitabine-induced supraventricular tachycardia: A rare manifestation
A1  - Linu Abraham
A1  - A Rudresha
A1  - Smitha Saldanha
A1  - Deepak Koppaka
A1  - Lakshmaiah Kuntegowdanahalli
A1  - Lokanatha Dasappa
A1  - Pretesh Kiran
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2016
VL  - 5
IS  - 2
DO  - 10.4103/2278-0513.178064
SP  - 200
EP  - 202
N2  - Gemcitabine is a cytotoxic drug with superior toxicity profile and widely used in the management of various solid malignancies. The common side effects associated with gemcitabine are myelosuppression, diarrhea, and flu-like symptoms. Cardiac side effects due to gemcitabine are very rare. We present a case of an elderly female aged 69 years, diagnosed to have metastatic carcinoma gallbladder, and without any cardiac risk factors, who developed supraventricular tachycardia 3 days after gemcitabine infusion. We emphasize the need for careful and routine cardiac monitoring in an elderly patient who develops symptoms of tachyarrhythmia when on gemcitabine therapy.
UR  - https://ccij-online.org/article/gemcitabine-induced-supraventricular-tachycardia:-a-rare-manifestation-573
ER  -